http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2193898-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_987e69b5a2809ab8caeadab2d6dd2859 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
filingDate | 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410f2b93afd541c6c73e4c299068543d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc9623a169c55b24738a4c436d4c4f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aecf6136c61cde8813dd951618785f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e1b69ac523c6d66ff14b5460275796 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecc1244f63fa0704d5346b82a268d77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91391a82bc8c58ed50ce761242a851d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_094b55c72e11d5212d53f0b645ba33f3 |
publicationDate | 2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2193898-C1 |
titleOfInvention | Method for supervision during the first half of induced pregnancy |
abstract | FIELD: medicine, obstetrics. SUBSTANCE: patients with uterine hypertonicity are suggested to undergo percutaneous electroneurostimulation at 60 Hz frequency, 0.6 ms impulse duration beginning since the 5-6th wk of pregnancy at intensivity to feel pleasant pain-free vibration once-twice daily at 2-3-h-long interval per 25-30 min at 5-6 procedures daily. It is, also, suggested to detect the value of thrombotic potential index and soluble complexes of fibrin monomers and at the increase of thrombotic potential index above 15 c. u. and/or appearance of positive value of soluble complexes of fibrin monomers it is necessary to conduct 3 seances of interrupted plasmapheresis at withdrawal of 30-50% volume of circulating plasma and plasma-substitution at the ratio to withdrawn plasma volume being 1.5 : 1 at 2-3- fold successive repetition of said procedures during pregnancy course. EFFECT: higher efficiency of supervision. 3 ex |
priorityDate | 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.